![]() Indeed, mental health illnesses are seen with increased prevalence in those with diabetes. Diabetes is recognised to have a significant impact on psychological outcomes and mental health. Several factors have a bearing on the achievement of glycated haemoglobin targets in people with diabetes. Chronically high glycated haemoglobin readings have been shown to negatively impact upon the physical health of people with diabetes: diabetes is one of the leading causes of adult blindness in the UK, increases the risk of cancer and dementia, more than doubles the risk of heart attack, trebles the risk of stroke and is the commonest cause of end-stage renal failure and non-traumatic lower limb amputation in Europe. Over time, glycated haemoglobin is a predictor of risk of developing diabetes complications. įor diabetes healthcare professionals, the importance of a personalised approach to management and goal-setting in people with diabetes has never been clearer, evidenced by the release of the joint American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) consensus statement. Far from being a standardised approach, glycated haemoglobin targets are often individualised to the patient in response to the presence of established cardiovascular disease, advanced age, long diabetes duration, frailty, excessive comorbidity, history of severe hypoglycaemia and comorbid mental health illness. Glycated haemoglobin values are commonly used to guide the management of people with diabetes. Sub-studies B and C will use qualitative semi-structured interviews to evaluate experiences, views and opinions of diabetes patients and healthcare professionals in relation to the acceptability of study processes, the use of glycated haemoglobin targets, the impact of diabetes on psychological well-being and, in sub-study D, barriers to participation in diabetes research. Psychometric outcomes will be re-evaluated 3-months post-intervention. Rates of eligibility, recruitment, retention and questionnaire response rate will be measured. ![]() Participants will be randomised to receive explicit glycated haemoglobin intervention targets 5mmol/mol above or below current glycated haemoglobin readings. In sub-study A, eligible adults (aged 18 and over) with type 1 or type 2 diabetes will complete baseline validated psychometric questionnaires evaluating health-related quality of life (EuroQoL-5D-5L), diabetes-related distress (Problem Areas In Diabetes), self-care (Summary of Diabetes Self-Care Activities), well-being (Well-Being Quetionnaire-12) and diabetes-related psychosocial self-efficacy (Diabetes Empowerment Scale-Long Form). ![]() This single-centre randomised feasibility study will follow a mixed-methods approach across four sub-studies.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |